Clinical Trials
2 trialsNCT05060237 2024-10-17
Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp
Biofrontera Bioscience GmbH
Phase 1 Completed
NCT02813902 2019-03-08
A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors
Massachusetts General Hospital
Phase 1 Withdrawn